Shear Wave Elastography Market Size & Forecast 2036

The global shear wave elastography market is developing as healthcare providers increasingly adopt advanced ultrasound technologies for non-invasive tissue assessment. Shear wave elastography (SWE) is an ultrasound-based imaging technique that evaluates tissue stiffness by measuring the propagation speed of shear waves through biological tissue. The resulting measurements can provide quantitative information that complements conventional ultrasound imaging and other clinical findings.

SWE is particularly relevant to the assessment of liver fibrosis and chronic liver conditions, where tissue stiffness measurements may help clinicians evaluate disease severity and monitor changes over time. Depending on the capabilities and approved indications of individual systems, the technology may also support selected breast, thyroid, musculoskeletal, and other diagnostic applications.

The market is influenced by increasing demand for non-invasive diagnostic procedures, growing interest in quantitative imaging, advances in ultrasound transducer technology, and the development of integrated diagnostic platforms. Healthcare providers are evaluating technologies that can deliver additional clinical information during ultrasound examinations while supporting efficient diagnostic workflows.

Technological developments are helping manufacturers improve image visualization, measurement tools, signal processing, and examination usability. Some systems incorporate automated measurement assistance, quality indicators, and software features designed to support consistent image acquisition and reporting. Artificial intelligence may further support workflow guidance and measurement analysis, subject to clinical validation and regulatory requirements.

Hospitals, diagnostic imaging centers, and specialist healthcare facilities represent important customer groups because they conduct a substantial volume of diagnostic imaging examinations. Adoption also depends on equipment budgets, the availability of trained professionals, reimbursement policies, clinical evidence, and integration with existing imaging infrastructure.

Despite its potential, shear wave elastography has technical and clinical limitations. Measurement results can be affected by the underlying condition, patient characteristics, acquisition technique, and equipment-specific methods. Healthcare professionals must interpret results within the appropriate clinical context rather than treating stiffness measurements as standalone diagnoses.

As healthcare providers continue to invest in advanced imaging technologies, SWE may gain further adoption in applications where quantitative tissue assessment contributes meaningfully to clinical decision-making.

Market Size & Forecast

The global shear wave elastography market is estimated at approximately USD 447.3 million in 2025 and USD 486.2 million in 2026 under the working forecast used in this report.

The market is projected to reach approximately USD 1.12 billion by 2036, assuming a compound annual growth rate (CAGR) of approximately 8.7% during 2026–2036.

Growth is expected to be influenced by the adoption of non-invasive liver assessment, technological improvements in diagnostic ultrasound, increased use of quantitative imaging, and the expansion of advanced imaging infrastructure.

The forecast represents a working scenario rather than a verified proprietary market measurement. Published estimates may differ because of variations in product coverage, technology definitions, geographic scope, and treatment of associated software and services. The figures should be validated against the final Lumera Research market model before publication as finalized market data.

Market Snapshot

Market Indicator

Working Estimate

Base year

2025

Market size, 2025

USD 447.3 million

Market size, 2026

USD 486.2 million

Forecast market size, 2036

Approximately USD 1.12 billion

Forecast CAGR, 2026–2036

Approximately 8.7%

Historical period

2020–2025

Forecast period

2026–2036

Primary technology scope

Ultrasound-based shear wave elastography

Important application

Liver fibrosis assessment

Key end users

Hospitals and diagnostic imaging centers

Market Growth Outlook

The market outlook reflects the potential for continued development in quantitative ultrasound and non-invasive tissue assessment.

Key factors include:

• Greater interest in non-invasive liver fibrosis evaluation.
• Integration of elastography into multipurpose ultrasound systems.
• Improvements in transducer design and signal processing.
• Increasing use of quantitative measurements in diagnostic workflows.
• Continued development of automated measurement and reporting tools.
• Expansion of healthcare infrastructure and advanced imaging services.
• Potential use in selected specialist imaging applications.
• Demand for technologies that complement conventional ultrasound examinations.

The actual growth rate will depend on clinical adoption, healthcare investment, product innovation, pricing, reimbursement, and the availability of appropriate clinical evidence.

Key Market Insights

Non-invasive diagnostic assessment: SWE can provide quantitative tissue-stiffness information during ultrasound examinations, supporting selected diagnostic and monitoring pathways.

Liver disease applications: Liver fibrosis assessment is an important clinical use case, although the role of SWE varies according to the disease, clinical setting, and applicable guidelines.

Integrated ultrasound platforms: Elastography-enabled ultrasound systems can combine conventional anatomical imaging with tissue-stiffness measurements.

Technology development: Advances in image processing, measurement tools, visualization, and workflow software may improve usability and measurement quality.

Clinical validation: Consistent examination protocols, suitable patient selection, and appropriate interpretation remain important for reliable results.

Regional opportunities: Adoption is influenced by diagnostic infrastructure, healthcare spending, equipment accessibility, and the availability of trained imaging professionals.

Competitive differentiation: Manufacturers compete through imaging capabilities, measurement reliability, software features, system integration, clinical support, and equipment cost.

These observations describe market characteristics and potential opportunities. They do not constitute independently verified market-share rankings.

Market Drivers

1. Growing Demand for Non-Invasive Diagnostic Techniques

Healthcare providers increasingly seek diagnostic approaches that can provide clinically useful information while reducing reliance on invasive procedures where appropriate. Shear wave elastography measures tissue stiffness using ultrasound-based methods and can support the assessment of selected medical conditions.

The technology may be particularly useful when clinicians require quantitative information to complement conventional imaging, laboratory findings, and patient history. Its suitability depends on the clinical indication and the performance of the specific system.

2. Increasing Focus on Liver Fibrosis Assessment

Chronic liver conditions create demand for methods that support fibrosis assessment and disease monitoring. Shear wave elastography can estimate liver stiffness and may contribute to clinical evaluation without requiring a biopsy for every assessment.

Growing attention to metabolic dysfunction-associated liver disease, viral hepatitis, and other chronic liver conditions may support demand for non-invasive assessment technologies.

The clinical interpretation of stiffness measurements must account for factors such as inflammation, congestion, and other conditions that can affect measurements independently of fibrosis.

3. Advancements in Ultrasound Technology

Improvements in transducer design, signal processing, image reconstruction, and quantitative measurement capabilities are helping manufacturers develop more sophisticated ultrasound systems.

SWE functionality can be incorporated into systems that also provide conventional imaging, enabling clinicians to assess anatomical structures and tissue stiffness during the same examination. Continued technical development may improve measurement consistency and workflow efficiency.

4. Integration With Multipurpose Ultrasound Platforms

Healthcare facilities often evaluate diagnostic equipment according to its ability to support multiple clinical applications. Integrating SWE into multipurpose ultrasound systems may make the technology more accessible to departments that already use ultrasound for routine diagnostic imaging.

The ability to combine conventional imaging with quantitative tissue assessment can influence purchasing decisions, particularly where equipment utilization, clinical versatility, and long-term value are important considerations.

5. Increasing Interest in Quantitative Imaging

Quantitative imaging provides numerical measurements that can complement visual interpretation. In SWE, tissue-stiffness measurements can contribute to assessment and follow-up when used within suitable clinical pathways.

Interest in repeatable measurements and longitudinal monitoring may encourage healthcare providers to evaluate elastography-enabled systems. Consistent acquisition protocols and awareness of measurement limitations remain necessary for meaningful comparisons.

6. Expansion of Diagnostic Imaging Infrastructure

Investment in hospitals, diagnostic imaging centers, and specialist medical services can increase demand for advanced ultrasound equipment. Healthcare infrastructure development may create opportunities for manufacturers offering elastography-enabled platforms.

Adoption will vary according to equipment budgets, clinical staffing, reimbursement arrangements, service availability, and the priorities of local healthcare systems.

7. Development of Automated Measurement Tools

Software features that assist with image acquisition, measurement placement, quality assessment, and report generation may help simplify elastography workflows.

Such tools may improve consistency and usability, although automation cannot eliminate the need for trained operators, appropriate clinical judgment, and product-specific validation.

8. Broader Clinical Research and Application Development

Research into elastography applications beyond liver assessment may create additional opportunities. Selected breast, thyroid, and musculoskeletal applications are areas of interest, depending on the technology, evidence base, and regulatory indications.

Expansion into these areas will depend on clinical validation, product development, healthcare guidelines, and demonstrated usefulness in specific diagnostic pathways.

Market Restraints

1. High Initial Equipment Costs

Advanced ultrasound systems equipped with elastography capabilities may require substantial capital investment. Smaller hospitals, independent diagnostic facilities, and healthcare providers with limited budgets may prioritize lower-cost imaging equipment.

Additional expenses can include transducers, software, training, maintenance, service agreements, and system upgrades.

2. Need for Specialized Training

Reliable elastography examinations require suitable patient preparation, image acquisition, measurement placement, and interpretation. Training requirements may slow adoption in healthcare facilities where experienced radiologists, sonographers, or other qualified professionals are limited.

Structured training and standardized protocols can help support more consistent clinical use.

3. Variability in Measurements

SWE measurements can be affected by disease characteristics, physiological conditions, patient factors, acquisition technique, and differences between equipment platforms.

Results from different systems or protocols may not always be directly interchangeable. These factors create a need for quality controls, standardized examination procedures, and careful clinical interpretation.

4. Reimbursement and Budget Constraints

Reimbursement policies for elastography examinations vary across healthcare systems, payers, clinical indications, and jurisdictions. Uncertainty regarding reimbursement, examination volumes, and the financial return on equipment investments may influence procurement decisions.

Healthcare facilities must evaluate the expected clinical value and operational use of elastography-enabled systems.

5. Uneven Access to Advanced Imaging

Access to advanced diagnostic imaging is not uniform across countries and healthcare settings. Some facilities may face challenges involving equipment affordability, maintenance, specialist staffing, and diagnostic infrastructure.

These barriers can limit adoption even where non-invasive tissue assessment may have potential clinical value.

6. Regulatory and Clinical Evidence Requirements

Medical imaging devices and related software must meet applicable regulatory requirements. Manufacturers may need to establish evidence supporting performance, safety, intended use, and product claims.

The time and investment required for regulatory compliance and clinical validation can influence product development and market expansion.

7. Integration and Workflow Challenges

Healthcare providers may need to integrate elastography functionality with existing ultrasound workflows, reporting systems, image archives, and clinical information platforms.

Implementation challenges can arise from differences in equipment, software compatibility, staff workflows, and data-management requirements.

8. Competition From Alternative Diagnostic Methods

Shear wave elastography operates within a wider diagnostic environment that includes other elastography techniques, conventional ultrasound, laboratory assessments, and selected invasive procedures.

Healthcare providers choose diagnostic methods according to the clinical question, available evidence, patient characteristics, equipment access, and applicable guidelines. This competitive environment can influence demand for individual SWE products.

Market Opportunities

1. Expansion of Liver Assessment Applications

Liver fibrosis assessment and monitoring remain important areas for SWE. Healthcare providers may use quantitative stiffness measurements as part of diagnostic pathways for selected patients with chronic liver conditions.

Opportunities depend on clinical evidence, appropriate patient selection, measurement quality, and integration with broader disease-management protocols.

2. Development of AI-Assisted Analysis

AI-enabled software may support image acquisition, measurement quality assessment, automated analysis, and reporting. Such tools could improve workflow usability and help standardize selected tasks.

Commercial opportunities will depend on demonstrated clinical value, system compatibility, regulatory authorization where required, and appropriate clinician oversight.

3. Growth in Integrated Imaging Systems

Ultrasound platforms combining conventional imaging with elastography may appeal to healthcare providers seeking multipurpose equipment. Manufacturers can differentiate their offerings through imaging performance, software functionality, usability, and service support.

4. Expansion Into Specialist Applications

Selected breast, thyroid, and musculoskeletal applications offer potential opportunities for elastography technology. Product-specific clinical indications and the availability of supporting evidence will determine the relevance of SWE in each setting.

5. Opportunities in Emerging Healthcare Markets

Healthcare infrastructure investment and increased access to diagnostic imaging may create opportunities across Asia Pacific, Latin America, and selected Middle Eastern and African markets.

Affordability, distribution networks, equipment servicing, training, and regulatory requirements will influence the adoption of elastography-enabled systems.

6. Software Upgrades and System Modernization

Healthcare facilities may consider upgrading compatible ultrasound systems to access improved measurement, visualization, or reporting capabilities. Software enhancements may provide an option for extending the utility of existing equipment where the hardware supports the required features.

7. Clinical Education and Training

Training initiatives can help healthcare professionals understand the capabilities and limitations of SWE and perform examinations more consistently. Manufacturers and education providers may collaborate with hospitals, universities, and professional organizations to develop appropriate training programs.

8. Research and Clinical Collaboration

Partnerships among equipment manufacturers, hospitals, research institutions, and clinical specialists can support evaluation of new applications, workflow improvements, and measurement protocols.

Such collaboration may contribute to better-defined use cases and more effective integration of elastography into clinical practice.

Global Shear Wave Elastography Market — Regional Analysis, Competitive Landscape & Report Coverage

Regional Insights

North America

North America represents an important market for shear wave elastography, supported by established healthcare infrastructure, advanced diagnostic imaging capabilities, and investment in medical technology. Hospitals, diagnostic imaging centers, and specialist healthcare facilities are potential users of elastography-enabled ultrasound systems.

The United States is an important market due to its large healthcare sector, availability of advanced medical imaging equipment, and ongoing demand for non-invasive diagnostic assessment. Canada also offers opportunities as healthcare providers modernize diagnostic services and expand access to specialist imaging.

Demand is influenced by equipment budgets, reimbursement policies, clinician training, clinical evidence, and the integration of elastography into existing diagnostic workflows. Manufacturers that can demonstrate clinical utility, measurement reliability, and workflow compatibility may be better positioned to serve healthcare providers.

Europe

Europe offers opportunities for shear wave elastography through established diagnostic imaging infrastructure, specialist healthcare services, and growing interest in quantitative ultrasound.

Germany, France, the United Kingdom, and Italy are important markets for advanced medical imaging. Healthcare providers may adopt elastography-enabled systems to support selected liver, breast, thyroid, and musculoskeletal assessments, depending on the system's capabilities and clinical indications.

Market development is influenced by public and private healthcare expenditure, equipment replacement cycles, procurement practices, reimbursement arrangements, and regulatory requirements. Clinical training and consistent measurement protocols remain important considerations for wider adoption.

Asia Pacific

Asia Pacific presents growth opportunities as healthcare infrastructure expands and demand increases for advanced diagnostic imaging. Investment in hospitals, diagnostic centers, and specialist medical services may support demand for ultrasound systems that incorporate quantitative tissue assessment.

China, Japan, and India represent important markets with different healthcare structures and adoption patterns. Japan has an established medical technology sector, China combines a large healthcare system with domestic equipment manufacturing, and India offers opportunities through healthcare infrastructure expansion and diagnostic service development.

Market adoption will depend on equipment affordability, local manufacturing capabilities, distribution networks, clinician training, and the availability of appropriate technical support. Differences in healthcare expenditure and access to advanced imaging will continue to influence demand across the region.

Latin America

The Latin American market is supported by gradual healthcare infrastructure modernization and demand for more advanced diagnostic imaging services. Brazil and Mexico represent important potential markets for elastography-enabled ultrasound systems.

Hospitals and diagnostic imaging centers may consider SWE as part of their efforts to expand non-invasive diagnostic capabilities, particularly for selected liver-related applications.

However, adoption can be affected by capital expenditure constraints, equipment affordability, reimbursement policies, access to trained professionals, and differences in healthcare infrastructure. Regional distribution partnerships and clinical education may support market development.

Middle East & Africa

The Middle East and Africa present opportunities for shear wave elastography as healthcare providers invest in advanced medical imaging and specialized diagnostic services.

Saudi Arabia and the United Arab Emirates are potential markets where healthcare modernization and investment in hospital infrastructure may support demand for advanced ultrasound technologies. South Africa also represents an important healthcare market within the region.

Adoption varies substantially by country and healthcare setting. Equipment cost, clinician availability, servicing, reimbursement, and access to specialist diagnostic facilities remain important factors influencing market development.

*Regional analysis is qualitative. These descriptions do not establish verified regional revenue shares, market rankings, or comparative CAGRs. Quantitative regional estimates should be incorporated only after validation against the final market model.*

Key Companies

The shear wave elastography market includes established medical imaging manufacturers and companies offering specialized diagnostic technologies. Competitive positioning depends on imaging performance, measurement capabilities, clinical applications, software integration, product availability, and service support.

Representative companies across the broader ultrasound and elastography ecosystem include:

• GE HealthCare
• Siemens Healthineers
• Koninklijke Philips N.V.
• Canon Medical Systems Corporation
• Mindray Bio-Medical Electronics
• Samsung Medison
• FUJIFILM Healthcare
• Esaote S.p.A.
• Echosens
• Hologic, Inc.

The companies operate across different parts of the medical imaging and diagnostic technology markets. Their inclusion does not imply that each company offers every type of SWE technology or that all listed businesses derive material revenue from shear wave elastography.

Competitive Landscape

Product and imaging capabilities: Manufacturers compete through image quality, measurement performance, supported imaging modes, and the clinical applications available on their platforms.

Software and workflow integration: Visualization tools, measurement assistance, reporting functionality, and integration with existing ultrasound workflows can influence purchasing decisions.

Clinical validation: Evidence supporting measurement performance and appropriate clinical use is important for healthcare providers evaluating advanced imaging systems.

Pricing and total ownership costs: Equipment pricing, maintenance, software licensing, training, and technical support can influence purchasing decisions, particularly for budget-constrained healthcare facilities.

Distribution and after-sales service: Regional distribution networks, product servicing, training availability, and technical support can affect the adoption of specialized imaging technologies.

Innovation and development: Advances in signal processing, transducer technology, quantitative imaging, and software-assisted analysis may create opportunities for product differentiation.

Market Trends

Integration of Elastography Into Diagnostic Ultrasound

Manufacturers continue to incorporate quantitative tissue assessment into multipurpose ultrasound platforms. Integration may allow healthcare providers to conduct conventional imaging and elastography examinations using the same system, subject to product capabilities.

Focus on Liver Fibrosis Assessment

Liver fibrosis assessment remains a key application for SWE. Interest in non-invasive disease evaluation and follow-up may support demand for ultrasound systems capable of providing quantitative stiffness measurements.

Improvements in Measurement Quality

Developments in signal processing, image visualization, measurement tools, and quality indicators may help improve the usability and consistency of SWE examinations.

AI-Assisted Imaging Workflows

AI-enabled functions may assist with measurement placement, image-quality assessment, workflow guidance, and report generation. The market impact will depend on product-specific validation, regulatory requirements, and demonstrated clinical value.

Expansion of Quantitative Imaging

Healthcare providers are evaluating quantitative imaging tools that complement conventional visual assessment. SWE can contribute numerical information to selected diagnostic pathways, although interpretation must account for patient characteristics, technical limitations, and other clinical findings.

Increasing Importance of Clinical Education

Training and standardized examination protocols are important to the effective use of elastography. Education programs may help healthcare professionals understand measurement limitations and integrate the technology appropriately into clinical workflows.

Customization & Consulting Support

The report can be customized according to business requirements and the availability of relevant market information.

Potential customization options include:

• Country-level market sizing
• Regional market analysis
• Technology-level segmentation
• Application-level segmentation
• Product portfolio analysis
• End-user analysis
• Competitive benchmarking
• Company profiling
• Ultrasound system capability comparison
• Elastography technology assessment
• Clinical application analysis
• Liver diagnostics market assessment
• Healthcare procurement analysis
• Medical imaging adoption assessment
• Pricing and equipment cost analysis
• Distribution channel assessment
• AI-assisted imaging analysis
• Regulatory and clinical adoption assessment
• Market-entry strategy
• Go-to-market planning
• Partnership and distribution assessment
• Investment opportunity analysis
• Custom market segmentation
• Strategic growth assessment

Customization can be aligned with the client's geographic priorities, target technologies, applications, competitor set, and research objectives.

Data Sources

The market assessment may use a combination of primary research, secondary research, company disclosures, clinical publications, and publicly available medical technology information.

The following categories represent potential research inputs. They do not indicate that every source has been consulted for this draft.

Primary Research

• Medical imaging equipment manufacturers
• Ultrasound technology developers
• Healthcare procurement professionals
• Hospital administrators
• Radiologists and sonographers
• Hepatology specialists
• Diagnostic imaging center operators
• Medical device distributors
• Clinical research professionals
• Healthcare technology consultants
• Medical imaging implementation specialists
• Ultrasound training organizations
• Clinical technology specialists
• Healthcare equipment procurement teams

Secondary Research

• Company annual reports and investor disclosures
• Official product documentation
• Manufacturer product announcements
• Regulatory databases and device-clearance information
• Government healthcare statistics
• Peer-reviewed clinical publications
• Medical imaging journals
• Clinical practice guidelines
• Professional medical association publications
• Public hospital procurement information
• Healthcare expenditure statistics
• Medical technology industry publications
• Relevant market research publications
• Publicly available product information

Market Estimation Methodology

Market estimation requires a consistent definition of shear wave elastography and the revenue categories included in the analysis.

The research model should distinguish ultrasound-based SWE from other elastography techniques, conventional ultrasound systems, and broader medical imaging markets. This helps reduce the risk of double counting related equipment or including technologies outside the intended market scope.

Historical estimates and future forecasts should be assessed using comparable product definitions, geographic coverage, and base-year assumptions.

Forecast assumptions may consider healthcare investment, equipment replacement cycles, technology development, adoption of non-invasive diagnostic methods, and changes in clinical practice.

Where reliable segment-level information is unavailable, the report should clearly distinguish qualitative assessments from quantified market estimates. All numerical figures should be reconciled with the final Lumera Research model before publication.

Who This Report Is For

Medical Imaging Equipment Manufacturers

Evaluate the market environment for elastography-enabled ultrasound systems, technology development, and potential product opportunities.

Healthcare Providers and Hospital Networks

Understand the role of SWE in diagnostic imaging and assess potential applications across hospitals, specialist departments, and imaging centers.

Ultrasound Technology Developers

Explore opportunities in transducer design, image processing, quantitative measurements, and software-assisted diagnostic workflows.

Medical Device Distributors

Assess regional demand, product categories, healthcare customer groups, and factors influencing equipment procurement.

Healthcare Investors

Review the market framework, technology trends, competitive environment, and potential growth opportunities in advanced diagnostic imaging.

Healthcare Consultants

Use the market assessment to support strategic planning, market-entry decisions, competitive analysis, and medical technology advisory work.

Diagnostic Imaging Center Operators

Evaluate market trends affecting advanced ultrasound equipment and quantitative imaging capabilities.

Research Institutions

Understand developments in shear wave elastography, clinical applications, measurement technology, and related diagnostic imaging markets.

Corporate Strategy and Business Development Teams

Assess opportunities for partnerships, product development, geographic expansion, and competitive positioning.

Why Buy This Report

Market Size and Forecast

Review the working market-size estimates and forecast outlook through 2036, with explicit assumptions and a distinction between benchmark figures and validated market measurements.

Technology Analysis

Understand the shear wave elastography landscape, including ultrasound-based technology categories, integrated systems, and developments in quantitative tissue assessment.

Application-Level Insights

Explore the role of SWE in liver fibrosis assessment and selected breast, thyroid, musculoskeletal, and other diagnostic applications, subject to product-specific indications.

Market Drivers and Restraints

Examine factors influencing adoption, including demand for non-invasive assessment, equipment costs, clinician training, measurement variability, reimbursement, and clinical evidence.

Regional Market Intelligence

Review the qualitative market environment across North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.

Competitive Intelligence

Identify representative companies operating across ultrasound systems, elastography technologies, and related diagnostic imaging markets.

Strategic Decision Support

Use the report framework to inform product planning, market entry, technology evaluation, distribution strategy, and investment discussions.

Emerging Opportunities

Explore potential opportunities in quantitative imaging, AI-assisted workflows, integrated ultrasound platforms, clinical education, and the expansion of selected diagnostic applications.

Report Coverage & Deliverables

• Market Size and Forecast
• Market Overview
• Market Trends
• Market Dynamics
• Growth Drivers
• Market Restraints
• Market Opportunities
• Technology Analysis
• Product Analysis
• Application Analysis
• End-User Analysis
• Regional Analysis
• Country-Level Analysis, subject to scope
• Competitive Landscape
• Company Profiles
• Product Capability Assessment
• Clinical Application Assessment
• Quantitative Imaging Trends
• AI-Assisted Imaging Analysis
• Healthcare Adoption Assessment
• Strategic Opportunity Analysis
• Future Market Outlook